4//SEC Filing
Rombotis Spiro George 4
Accession 0001104659-23-009910
CIK 0001130166other
Filed
Feb 1, 7:00 PM ET
Accepted
Feb 2, 4:18 PM ET
Size
5.3 KB
Accession
0001104659-23-009910
Insider Transaction Report
Form 4
Rombotis Spiro George
DirectorPresident & C.E.O.
Transactions
- Award
Common Stock
2023-01-31+57,600→ 62,588 total
Footnotes (2)
- [F1]The reporting person received an award of 57,600 restricted stock units on January 31, 2023, which shall vest in full on January 31, 2026, provided, however, that if certain clinical milestones are achieved then such restricted stock units shall vest in full earlier in connection with such achievement.
- [F2]Includes 4,988 shares of common stock and 57,600 restricted stock units.
Documents
Issuer
Cyclacel Pharmaceuticals, Inc.
CIK 0001130166
Entity typeother
Related Parties
1- filerCIK 0001357396
Filing Metadata
- Form type
- 4
- Filed
- Feb 1, 7:00 PM ET
- Accepted
- Feb 2, 4:18 PM ET
- Size
- 5.3 KB